EXAGEN INC. (XGN) Social Stream
EXAGEN INC (XGN) Price Targets From Analysts
Use the tables below to see what analysts covering EXAGEN INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-15 | 5 | $33 | $24 | $27 | $1.99 | 1256.78% |
| 2021-11-12 | 5 | $30 | $24 | $26.25 | $1.99 | 1219.1% |
| 2022-01-14 | 5 | $30 | $23 | $26 | $1.99 | 1206.53% |
| 2022-03-24 | 4 | $20 | $16 | $18.333 | $1.99 | 821.26% |
| 2022-05-13 | 4 | $19 | $16 | $17.333 | $1.99 | 771.01% |
| 2022-08-05 | 4 | $17 | $14 | $15.666 | $1.99 | 687.24% |
| 2022-08-29 | 5 | $17 | $10 | $13.666 | $1.99 | 586.73% |
| 2022-11-15 | 5 | $14 | $7 | $10.333 | $1.99 | 419.25% |
| 2022-11-17 | 6 | $9 | $7 | $7.5 | $1.99 | 276.88% |
| 2023-01-20 | 6 | $7 | $6 | $6.666 | $1.99 | 234.97% |
| 2023-03-20 | 6 | $7.001 | $6 | $6.75 | $1.99 | 239.2% |
| 2023-08-09 | 6 | $7 | $5 | $6.25 | $1.99 | 214.07% |
| 2023-10-23 | 6 | $7 | $5 | $5.75 | $1.99 | 188.94% |
The Trend in the Analyst Price Target
Over the past 41 months, XGN's average price target has gone down $12.75.
Over the past 39 weeks, XGN's average upside potential has been 161.19%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-20 | 6 | 7.000 | 6 | 6.666 | 2.860 | 133.08% |
| 2023-03-20 | 6 | 7.001 | 6 | 6.750 | 2.350 | 187.23% |
| 2023-05-17 | 6 | 7.000 | 5 | 6.250 | 3.240 | 92.9% |
| 2023-08-09 | 6 | 7.000 | 5 | 6.250 | 2.570 | 143.19% |
| 2023-10-23 | 6 | 7.000 | 5 | 5.750 | 1.614 | 256.26% |
XGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 5 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
XGN's average broker recommendation rating improved by 0.17 over the prior 14 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how EXAGEN INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1688.57% of that group.
- To contextualize these metrics, consider that out of all US stocks, EXAGEN INC's average analyst price target is greater than 305.27% of them.
- EXAGEN INC's number of analysts covering the stock is higher than 355.81% of Healthcare stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, EXAGEN INC's variance in analysts' estimates is lower than -334.3% of them.
Stocks similar to EXAGEN INC in the Healthcare industry regarding analyst recommendations and price targets are CSTL, PSNL, and BDSX.
View All Top Stocks by Price Target
Make investment decisions regarding XGN using the data that counts. Try POWR Ratings for free.